Navigation Links
Protein Research Marketing Insights
Date:9/23/2008

ARLINGTON, Va., Sept. 23 /PRNewswire/ -- BioInformatics, LLC (http://www.gene2drug.com), the leading market research and consulting firm serving the life science industry, announces the publication of its latest report, "Protein Research: Strategies for Marketing to Chemists and Biologists." A joint effort between BioInformatics, LLC and the American Chemical Society, the report is designed to help suppliers of protein research tools and technologies identify workflow patterns and applications, discover unmet technology needs and explore instrument-purchasing drivers among biologists and chemists.

"A more in-depth understanding of the needs of scientists studying protein research is of growing importance as the field becomes more complex and funding sources become harder to obtain," observed Dr. Tamara Zemlo, Director of Syndicated Research and Analysis for BioInformatics, LLC. "Furthermore, we have identified significant overlap in how biologists and chemists use the equipment, thereby allowing companies to streamline the marketing effort to appeal to scientists in both disciplines."

By exploring the usage and purchase drivers behind both the higher dollar mass spectrometry and HPLC instrumentation, and the less expensive electrophoresis equipment products, manufacturers and scientists alike can understand what, in addition to cost, is influencing purchase decisions. This study explores how these preferences play out differently (and the same) between biologists and chemists.

Designed to help identify key areas of investigation among protein researchers, perceived bottlenecks, potential budgetary implications and customer perceptions of leading providers of instrumentation, this benchmarking study allows suppliers to gain keen insight into the evolving needs of their protein research customers, while more clearly defining certain industry-wide best practices. The information in this report can be used to provide direction as to how suppliers can increase sales volume through innovative product offerings and continue to better meet the needs of current users.

"One of the greatest areas of concern is an ability to meet the higher demand for increased throughput," Zemlo noted. Contained within the report are "Scorecards" for each of the instruments studied. These scorecards provide at-a-glance information as to how biologists and chemists use their protein research tools, what features are most important to them and what kind of purchase criteria they use for choosing vendors.

"Protein Research: Strategies for Marketing to Chemists and Biologists" is based on responses to a 53-question online survey conducted by BioInformatics, LLC. 275 chemists and 443 biologists from North America completed an online survey fielded between June 25 and August 1, 2008. Plan to attend a free webinar to discuss this report on Wednesday, October 22 at 1pm EDT. To register for your virtual seat at the webinar, email m.follin@gene2drug.com. For a complimentary Executive Summary of this report, please visit http://www.gene2drug.com/report/197/

ABOUT BIOINFORMATICS, LLC

BioInformatics, LLC is the premier research and advisory firm serving the life science industry. By leveraging our professional social network of more than 38,000 biomedical researchers, we have supported more than 300 companies and provided insights that lead to better business decisions. Our assignments include assessing the size and attractiveness of markets, optimizing product configurations and pricing, validating corporate acquisitions, measuring customer loyalty, and evaluating brand strength and positioning.

For more information, please contact:

Mary Follin

Director of Communications

BioInformatics, LLC

2111 Wilson Blvd., Suite 250

Arlington, VA 22201

703.778.3080 x13 (phone)

m.follin@gene2drug.com

http://www.gene2drug.com/


'/>"/>
SOURCE BioInformatics, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Vermillion and Collaborators Discover Protein Biomarker Associated with Peripheral Artery Disease
2. China-Biotics, Inc. Launches Shining Probiotics Protein Powder
3. When proteins, antibodies and other biological molecules kiss, a new kind of biosensor can tell
4. When proteins, antibodies and other biological molecules kiss, a new kind of biosensor can tell
5. New Data Presented on Immunocytokine Fusion Protein Further Supports Broad Anti-Cancer Potential Of Peregrines Anti-PS Technology Platform
6. Baxter Adds Recombinant Protein to Specialty Therapeutics Portfolio
7. Decision Biomarkers Awarded U.S. Patent for Protein Array Surface Chemistry
8. STALLERGENES and Protein eXpert Enter Into a Partnership for Producing Mites Recombinant Allergens
9. Alfacell Announces ONCONASE(R) Purchase and Supply Agreement with Scientific Protein Laboratories
10. Decision Biomarkers Launches System for Faster, Easier Quantification of Protein Biomarkers
11. Immune system protein starves staph bacteria
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... SAN DIEGO , June 24, 2016 /PRNewswire/ ... that more sensitively detects cancers susceptible to PARP ... individual circulating tumor cells (CTCs). The new test ... of HRD-targeted therapeutics in multiple cancer types. ... therapies targeting DNA damage response pathways, including PARP, ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with ... in this eBook by providing practical tips, tools, and strategies for clinical researchers. ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
Breaking Biology Technology:
(Date:6/7/2016)...  Syngrafii Inc. and San Antonio Credit Union ... integrating Syngrafii,s patented LongPen™ eSignature "Wet" solution into ... result in greater convenience for SACU members and ... existing document workflow and compliance requirements. ... Highlights: ...
(Date:6/2/2016)... , June 2, 2016   The Weather Company , ... Watson Ads, an industry-first capability in which consumers will be ... able to ask questions via voice or text and receive ... Marketers have long sought an advertising ... that can be personal, relevant and valuable; and can scale ...
(Date:5/24/2016)... Ampronix facilitates superior patient care by providing unparalleled technology to leaders of ... the latest premium product recently added to the range of products distributed by Ampronix. ... ... ... Medical Display- Ampronix News ...
Breaking Biology News(10 mins):